Fresenius Medical Care AGFMS決算レポート
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
FMS Q4 2025 Key Financial Metrics
売上高
$5.5B
粗利益
$1.5B
営業利益
$641.4M
純利益
$434.2M
粗利益率
27.4%
営業利益率
11.7%
純利益率
7.9%
前年比成長
-0.3%
資金フロー
Fresenius Medical Care AG Q4 2025 財務サマリー
Fresenius Medical Care AG reported revenue of $5.5B (down 0.3% YoY) for Q4 2025, with a net profit of $434.2M (up 240.4% YoY) (7.9% margin). Cost of goods sold was $4.0B, operating expenses totaled $858.1M.
主要財務指標
| 総売上高 | $5.5B |
|---|---|
| 純利益 | $434.2M |
| 粗利益率 | 27.4% |
| 営業利益率 | 11.7% |
| 報告期間 | Q4 2025 |
Fresenius Medical Care AG 四半期売上・純利益の履歴
Fresenius Medical Care AG quarterly results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| 四半期 | 売上高 | 売上前年比 | 純利益 | 純利益率 |
|---|---|---|---|---|
| Q4 2025 | $5.5B | -0.3% | $434.2M | 7.9% |
| Q4 2024 | $5.5B | +1.9% | $127.6M | 2.3% |
損益計算書
| Q4 2024 | Q4 2025 | |
|---|---|---|
| 売上高 | $5.49B | $5.48B |
| 前年比成長 | 1.9% | -0.3% |
貸借対照表
| Q4 2024 | Q4 2025 | |
|---|---|---|
| 総資産 | $36.25B | $33.48B |
| 総負債 | $19.22B | $18.06B |
| 株主資本 | $17.03B | $15.43B |
キャッシュフロー
| Q4 2024 | Q4 2025 | |
|---|---|---|
| 営業CF | $2.58B | $2.90B |